While 'too big to fail' often describes megacap stocks, their massive scale presents a double-edged sword, potentially capping growth. We analyze the prospects for Tesla, Micron, and IBM in a challenging market.
In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.
A landmark investment proposal between AI titans Nvidia and OpenAI has stalled, with both companies reassessing terms amid internal concerns and a shifting competitive landscape, according to a Wall Street Journal report.
The all-stock deal creates a top-tier independent producer focused on the Permian Basin, with Beth McDonald at the helm aiming to unlock significant synergies and shareholder returns.
The Walt Disney Company reported a 5% rise in fiscal first-quarter revenue to $26 billion, fueled by its theme parks and streaming services. However, operating profit fell 9% as challenges in its traditional TV business and rising costs offset gains.
Foundation Investment Partners, through its platform Sustainable Packaging, has acquired Paper Converters, a Walterboro-based manufacturer of spiral-wound paper tubes and boards, marking a strategic consolidation in the eco-friendly packaging sector.
With the cost of living significantly higher than just a few years ago, Channel 11's Susan Koeppen offers actionable tips to help households reduce recurring bills and ease financial pressure.
A hefty cash reserve is typically a corporate strength, but for some companies, it signals stagnation rather than security. We examine three firms—Box, C3.ai, and Novavax—where significant net cash positions fail to offset concerns over growth prospects and valuation.
As e-commerce reshapes retail, some traditional consumer stocks struggle to keep pace. We examine three companies where valuation concerns and shifting market dynamics signal potential risk for investors.
While the S&P 500 is a barometer of corporate America, not all its components are created equal. We analyze one stock to approach with caution and two others demonstrating compelling market momentum.
The industrial sector has been a quiet powerhouse, outpacing the broader market. Yet, amid the rally, some prominent names carry significant risks that warrant a closer look from investors.
The business services sector has mirrored the broader market's gains, but a wave of AI-driven disruption is separating the resilient from the vulnerable. We analyze one stock facing headwinds and two with the fundamentals to potentially thrive.
While the S&P 500 is a bastion of market stability, not all its constituents offer equal promise. We analyze one professional services giant and one industrial technology leader showing robust potential, alongside a consumer electronics retailer facing significant headwinds.
As economic uncertainty weighs on consumer spending, discretionary stocks have lagged the broader market. We examine three companies—TEGNA, Sabre, and Compass—whose business models and valuations raise significant questions for investors in the current climate.
While rapid growth can inflate valuations, its sustainability separates market leaders from laggards. We analyze one company extending its competitive moat and two others where investors should tread carefully.
Despite a strong three-year run, shares of Ollie's Bargain Outlet (OLLI) dipped this week, prompting investors to weigh its solid earnings growth against recent market performance.
Despite posting impressive revenue and subscriber growth in 2025, Netflix faces a critical headwind: its share of viewer engagement is growing at a fraction of the overall streaming market's pace, signaling intensified competition for attention.
French reinsurer SCOR has expanded its underwriting capacity for Baobab Insurance's cyber policies in Germany and Austria, now covering companies with annual revenues up to €1 billion, marking a strategic push into Europe's industrial cyber risk market.
While Vidhance (FRA:8W50) continues to operate at a loss, its current cash reserves and manageable burn rate suggest the company has time to execute its growth strategy. However, a recent dip in revenue adds a note of caution for investors.
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
